Search results for "Cardiovascular diseases."

showing 10 items of 2156 documents

A multiple biomarker risk score for guiding clinical decisions using a decision curve approach.

2011

Aims: We assessed whether a cardiovascular risk model based on classic risk factors (e.g. cholesterol, blood pressure) could refine disease prediction if it included novel biomarkers (C-reactive protein, N-terminal pro-B-type natriuretic peptide, troponin I) using a decision curve approach which can incorporate clinical consequences. Methods and results: We evaluated whether a model including biomarkers and classic risk factors could improve prediction of 10 year risk of cardiovascular disease (CVD; chronic heart disease and ischaemic stroke) against a classic risk factor model using a decision curve approach in two prospective MORGAM cohorts. This included 7739 men and women with 457 CVD …

AdultMalemedicine.medical_specialtyEpidemiologymedicine.drug_classBlood PressureDiseaseRisk AssessmentDecision Support TechniquesSex FactorsPredictive Value of TestsRisk FactorsInternal medicineTroponin INatriuretic Peptide BrainmedicineNatriuretic peptideHumansRisk thresholdProspective StudiesFramingham Risk Scorebusiness.industryTroponin IAge FactorsMiddle AgedPrognosisPeptide FragmentsSurgeryEuropeBlood pressureC-Reactive ProteinCholesterolCardiovascular DiseasesCohortBiomarker (medicine)FemaleCardiology and Cardiovascular MedicinebusinessBiomarkersEuropean journal of preventive cardiology
researchProduct

Coronary artery stenosis treatment in aging patients with inherited Factor VII deficiency: Where do we stand?

2017

Aging with rare bleeding disorders such as factor VII (FVII) deficiency poses several challenges to treatment because of the occurrence of cerebral and cardiovascular age-related comorbidities and high bleeding risks. We report a case of long-term treatment with antiplatelet agents and contemporary prophylaxis of bleeding in a woman affected by severe FVII deficiency diagnosed with symptomatic coronary artery stenosis. Information on the management of antithrombotic treatment in rare bleeding disorders is lacking and mainly limited to anecdotal reports or side effects secondary to replacement therapy. We also briefly reviewed available data on the treatment of arterial thrombosis in FVII de…

AdultMalemedicine.medical_specialtyFactor VII DeficiencyCardiovascular risk factorsCoronary stenosis030204 cardiovascular system & hematology03 medical and health scienceschemistry.chemical_compoundAntithrombotic treatment0302 clinical medicineInternal medicinemedicineHumanscardiovascular diseasesFactor VII deficiencyChildAgedFactor VIIbusiness.industryCoronary StenosisHematologyMiddle Agedmedicine.diseaseThrombosischemistryCardiologyFemalebusiness030215 immunologyTransfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis
researchProduct

The role of plasma triglyceride/high-density lipoprotein cholesterol ratio to predict cardiovascular outcomes in chronic kidney disease.

2015

Background Cardiovascular disease (CVD) risk is substantially increased in subjects with chronic kidney disease (CKD). The Triglycerides (TG) to High-Density Lipoprotein Cholesterol (HDL-C) ratio is an indirect measure of insulin resistance and an independent predictor of cardiovascular risk. No study to date has been performed to evaluate whether the TG/HDL-C ratio predicts CVD risk in patients with CKD. Methods A total of 197 patients (age 53 ± 12 years) with CKD Stages 1 to 5, were enrolled in this longitudinal, observational, retrospective study. TG/HDL-C ratio, HOMA-IR indexes, serum asymmetric dimethyl arginine (ADMA), high sensitivity C-reactive protein (CRP), parathyroid hormone (PT…

AdultMalemedicine.medical_specialtyFlow mediated dilatationTriglyceride to HDL-cholesterol ratioEndocrinology Diabetes and MetabolismAsymmetric dimethyl arginineClinical BiochemistryRenal functionClinical nutritionArginineGastroenterologychemistry.chemical_compoundEndocrinologyInsulin resistanceHigh-density lipoproteinInternal medicineChronic kidney diseasemedicineHumansLongitudinal StudiesRenal Insufficiency ChronicSerum AlbuminTriglyceridesAgedRetrospective StudiesBiochemistry medicalbiologybusiness.industryCholesterolResearchBiochemistry (medical)C-reactive proteinCholesterol HDLMiddle Agedmedicine.diseaseEndocrinologyC-Reactive ProteinchemistryCardiovascular DiseasesParathyroid Hormonebiology.proteinlipids (amino acids peptides and proteins)FemalebusinessBiomarkersKidney diseaseLipidologyGlomerular Filtration RateLipids in health and disease
researchProduct

Gender Inequalities in Diagnostic Inertia around the Three Most Prevalent Cardiovascular Risk Studies: Protocol for a Population-Based Cohort Study

2021

Evidence shows that objectives for detecting and controlling cardiovascular risk factors are not being effectively met, and moreover, outcomes differ between men and women. This study will assess the gender-related differences in diagnostic inertia around the three most prevalent cardiovascular risk factors: dyslipidemia, arterial hypertension, and diabetes mellitus, and to evaluate the consequences on cardiovascular disease incidence. This is an epidemiological and cohort study. Eligible patients will be adults who presented to public primary health care centers in a Spanish region from 2008 to 2011, with hypertension, dyslipidemia, or/and diabetes and without cardiovascular disease. Parti…

AdultMalemedicine.medical_specialtyHealth Toxicology and Mutagenesislcsh:MedicineDisease030204 cardiovascular system & hematologyCohort Studies03 medical and health sciencesStudy Protocol0302 clinical medicineRisk FactorsEpidemiologyHealth caremedicineHumansrisk factors030212 general & internal medicinebusiness.industryPublic healthMedical recordlcsh:Rpublic healthPublic Health Environmental and Occupational Healthmedicine.diseasecardiovascular diseasessex factorsCross-Sectional Studiesdisease managementCardiovascular DiseasesHeart Disease Risk FactorsCohortEmergency medicineFemalebusinessDyslipidemiaCohort study
researchProduct

In-hospital complications of acute myocardial infarction in hypertensive subjects

2005

Recent studies have shown a worse in-hospital outcome in hypertensive than in normotensive patients with acute myocardial infarction (AMI), which has been attributed to more frequent complications. The aim of this study was to investigate clinical patterns, risk factors, and in-hospital complications in hypertensive and normotensive patients with AMI.Of 4994 consecutive patients with AMI admitted to the intensive care unit, hypertensive patients with first infarction (n = 915; mean age 68.8 +/- 11.4 years) and 915 gender- and age-matched normotensive subjects were retrospectively studied.In the univariate analysis, hypertensive subjects presented more frequently non-Q-wave infarction and ST…

AdultMalemedicine.medical_specialtyHeart DiseasesMyocardial InfarctionInfarctionlaw.inventionElectrocardiographylawInternal medicineDiabetes mellitusInternal MedicinemedicineHumansST segmentcardiovascular diseasesMyocardial infarctionAntihypertensive AgentsAgedRetrospective StudiesAged 80 and overST depressionInpatientsUnivariate analysisbusiness.industryCoronary Care UnitsMiddle Agedmedicine.diseaseIntensive care unitCase-Control StudiesHypertensionCardiologyFemalemedicine.symptombusinessDyslipidemiaAmerican Journal of Hypertension
researchProduct

Relation of endocrine and cardiac findings in acromegalics

1992

Cardiac involvement in 32 acromegalics was related to endocrine parameters, clinical score and duration of the disease as well as compared to that of 50 controls free of cardiac disease. Stress ECG, 24h Holter monitoring and echocardiography revealed that supraventricular premature complexes did not occur more often in acromegalics than in controls, both prevalence and severity of ventricular arrhythmia, however, were higher in patients compared to controls: 15/32 (48%) acromegalics had complex ventricular arrhythmia as compared with 6/50 (12%) normal subjects (p less than 0.01). Repetitive ventricular arrhythmia was manifest in 10/32 (31%) patients but only in 4/50 (8%) controls (p less th…

AdultMalemedicine.medical_specialtyHeart diseaseAdenomaEndocrinology Diabetes and MetabolismConcentric hypertrophyCardiomegalyLeft ventricular hypertrophySeverity of Illness IndexElectrocardiographyEndocrinologyInternal medicineAcromegalyPrevalenceHumansMedicinecardiovascular diseasesPathologicalAgedbusiness.industryArrhythmias CardiacMiddle Agedmedicine.diseaseCircadian RhythmEndocrinologyGrowth HormoneAcromegalycardiovascular systemCardiologyFemalebusinessComplicationHormoneJournal of Endocrinological Investigation
researchProduct

Effects of drug therapy on cardiac arrhythmias and ischemia in hypertensives with LVH.

2001

Left ventricular hypertrophy (LVH) in hypertensive subjects is associated with an increased prevalence of ventricular arrhythmias. To evaluate the effect of antihypertensive treatment on cardiac arrhythmias (CA) and transient episodes of myocardial ischemia (TEMI), we studied 46 hypertensive patients with LVH, divided into four groups randomly treated with enalapril, hydrochlorothiazide (HCTZ), atenolol, or verapamil (SR-V) for 6 months. Office blood pressure and office heart rate values were recorded, in basal conditions, after 1 and 6 months of treatment, and all patients underwent echocardiography, electrocardiographic Holter monitoring, and stress testing. All drugs significantly lowere…

AdultMalemedicine.medical_specialtyHeart diseaseMyocardial IschemiaBlood PressureLeft ventricular hypertrophyHydrochlorothiazideEnalaprilInternal medicineHeart rateInternal MedicinemedicineHumanscardiovascular diseasesEnalaprilAntihypertensive AgentsAgedmedicine.diagnostic_testbusiness.industryArrhythmias CardiacMiddle Agedmedicine.diseaseAtenololBlood pressureHydrochlorothiazideTreatment OutcomeAtenololVerapamilHypertensioncardiovascular systemCardiologyElectrocardiography AmbulatoryFemaleHypertrophy Left VentricularbusinessElectrocardiographyAnti-Arrhythmia Agentsmedicine.drugAmerican journal of hypertension
researchProduct

The effect of radiofrequency catheter ablation of frequent premature ventricular complexes and arrhythmia burden on left ventricular function

2016

Background: Frequent premature ventricular complexes (PVC) are related to reversible tachycardia-induced cardiomyopathy. However, the role of arrhythmia burden on the outcome of the catheter ablation has not been fully recognised. Aim: The aim of this study was to assess the effect of catheter ablation and PVC burden in patients with and without structural heart disease (SHD) on left ventricular ejection fraction (LVEF). Methods: Transthoracic echocardiography was done before and six months after radiofrequency catheter ablation in 109 consecutive patients (61 men, age 55 ± 17 years) with frequent PVCs. Sixty-five (59.6%) patients had underlying SHD. Results: The catheter ablation procedure…

AdultMalemedicine.medical_specialtyHeart diseasemedicine.medical_treatmentCardiomyopathyCatheter ablation030204 cardiovascular system & hematologyVentricular Dysfunction Left03 medical and health sciencesQRS complex0302 clinical medicineInternal medicinemedicineHumanscardiovascular diseases030212 general & internal medicineventricular arrhythmiaAgedEjection fractionbusiness.industryleft ventricular ejection fractionStroke VolumeStroke volumeMiddle Agedmedicine.diseaseAblationstructural heart diseaseVentricular Premature ComplexesTreatment OutcomeEchocardiographyConcomitantMultivariate AnalysisCatheter Ablationcardiovascular systemCardiologyFemalepremature ventricular complexCardiology and Cardiovascular MedicinebusinessKardiologia Polska
researchProduct

Thyroid hormone receptor alpha gene variants increase the risk of developing obesity and show gene-diet interactions.

2013

Thyroid hormone receptor-beta resistance has been associated with metabolic traits. THRA gene sequencing of an obese woman (index case) who presented as empirical thyroid hormone receptor-α (THRA) resistance, disclosed a polymorphism (rs12939700) in a critical region involved in TRα alternative processing.THRA gene variants were evaluated in three independent europid populations (i) in two population cohorts at baseline (n=3417 and n=2265), 6 years later (n=2139) and (ii) in 4734 high cardiovascular risk subjects (HCVR, PREDIMED trial).The minor allele of the index case polymorphism (rs12939700), despite having a very low frequency (4%), was significantly associated with higher body mass in…

AdultMalemedicine.medical_specialtyHeterozygoteEndocrinology Diabetes and MetabolismPopulationMedicine (miscellaneous)Polymorphism Single NucleotideBody Mass IndexHypothyroidismRisk FactorsInternal medicinemedicineHumansGenetic Predisposition to DiseaseObesityeducationeducation.field_of_studyNutrition and DieteticsThyroid hormone receptorbusiness.industryThyroidOdds ratioMiddle Agedmedicine.diseaseObesityDietary FatsMinor allele frequencymedicine.anatomical_structureEndocrinologyCross-Sectional StudiesCardiovascular DiseasesSpainFemaleFranceInsulin ResistancebusinessEnergy IntakeBody mass indexHormoneThyroid Hormone Receptors alphaInternational journal of obesity (2005)
researchProduct

Homocysteine levels and the metabolic syndrome in a Mediterranean population: A case-control study

2011

Hyperhomocysteinemia (HH) and metabolic syndrome (MS) are associated with increased cardiovascular risk. However, whether there is a link between MS or its components and homocysteine levels in a population without cardiovascular disease is not well established. We conducted a case-control study in 61 MS patients (41 males, 20 females, aged 51 ± 11 years) and in 98 controls without MS (59 males, 39 females, aged 50 ± 10 years) to ascertain the association between MS and HH, and with inflammatory markers. MS was classified according to the updated ATPIII criteria [17]. No differences in homocysteine levels were observed when comparing MS patients and controls (12.0 ± 3.18 μM vs. 11.9 ± 3.5 μ…

AdultMalemedicine.medical_specialtyHyperhomocysteinemiaHomocysteinePhysiologyPopulationHyperhomocysteinemiachemistry.chemical_compoundPhysiology (medical)Internal medicineDiabetes mellitusHumansMedicineeducationHomocysteineAbdominal obesityMetabolic Syndromeeducation.field_of_studyCreatininebusiness.industryHypertriglyceridemiaHematologyMiddle Agedmedicine.diseaseEndocrinologychemistryCardiovascular DiseasesCase-Control StudiesFemalemedicine.symptomMetabolic syndromeCardiology and Cardiovascular MedicinebusinessClinical Hemorheology and Microcirculation
researchProduct